Pharmacopeia Drug Discovery Appoints Martin H. Soeters and Dennis Langer to Board of Directors; Company Also Changes Name to Pharmacopeia, Inc.

PRINCETON, N.J., May 7 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP - News), an innovator in the discovery and development of novel small molecule therapeutics, today announced the elections of Martin H. Soeters and Dennis Langer, M.D., J.D., to the company's Board of Directors. Mr. Soeters and Dr. Langer bring extensive pharmaceutical industry experience to Pharmacopeia's board, offering high-level expertise in a variety of key business areas such as product development, marketing, and sales. They will replace James J. Marino, Esq. and Gary E. Costley, Ph.D., on Pharmacopeia's board.